Xeris Biopharma Holdings, Inc. XERS Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s prepaid & other current?
- Xeris Biopharma Holdings, Inc. (XERS) reported prepaid & other current of $9.4M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s prepaid & other current changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s prepaid & other current increased by 55.8% year-over-year, from $6.03M to $9.4M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s prepaid & other current has grown at a 24.5% compound annual growth rate (CAGR), from $3.2M to $9.55M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.